Day: January 30, 2025

Homeowners not leveraging available technology to reduce energy costs and emissions, says report from Schneider Electric

Written by Customer Service on January 30, 2025. Posted in Public Companies.

Although 70% of survey respondents recognize the importance of reducing their carbon footprint, many are still opting for small-scale solutions.Turning off lights is the most common energy-saving method, but accounts for just 5% of average energy bills. However, only 44% of respondents adjusted their ambient temperature, representing over half of household energy use. Rueil-Malmaison, France, Jan. 30, 2025 (GLOBE NEWSWIRE) — Schneider Electric, the leader in the digital transformation of energy management and automation, today released the third edition of its consumer survey in a white paper titled Evolving home energy consumption: Intentions, actions and hurdles to greater home energy efficiency. It surveyed 13,000 people from 11 countries across the world uncovering global attitudes toward household energy efficiency, sustainability...

Liven AS – Consolidated unaudited interim report for the IV quarter and 12 months of 2024

Written by Customer Service on January 30, 2025. Posted in Earnings Releases And Operating Results.

A webinar on the presentation of the results (in Estonian only) will take place on 30 January at 13:00 (EET), more information. Although there were no huge positive development leaps in the operating environment, there were still signs of renewed optimism in the residential property market. During the fourth quarter, we signed 34 contracts under the law of obligation (sales contract; 2024 Q3: 32; 2023 Q4: 29) and in total during 12 months, we signed 129 sales contracts (2023: 69). Most of the new sales during the quarter came from the Uus Meremaa ready for sale homes and from signing new sale contracts for the Iseära phase II terraced houses and apartments under construction. The number of new sales contracts signed during the year is Liven’s highest annual performance to date. Liven’s market share of new sales in Tallinn and...

Karolinska Development’s portfolio company Dilafor advances tafoxiparin following successful meetings with FDA and European regulatory authorities

Written by Customer Service on January 30, 2025. Posted in Public Companies.

STOCKHOLM, SWEDEN – January 30, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Dilafor has successfully completed regulatory meetings with the U.S. Food and Drug Administration, FDA, and European Health Agencies, regarding the continued development of the company’s drug candidate tafoxiparin. The completed meetings mark the end of a comprehensive dialogue with regulatory authorities in the US and EU to reach an alignment between the authorities on designing pivotal clinical Phase 3 studies in Europe and the US to evaluate tafoxiparin as a new potential treatment for priming of labor. Dilafor has completed interactions with US and European authorities during 2023 – 2024 to achieve an alignment in the regulatory process ahead of the upcoming clinical phase 3 trials with the company’s drug...

GENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan

Written by Customer Service on January 30, 2025. Posted in Public Companies.

GENFIT signs royalty financing deal with HealthCare Royalty (HCRx) providing up to €185 million non-dilutive capital: €130 million upfront, with eligibility to receive up to €55 million in two additional instalments based on near-term milestones Closing subject to approval by the 2025 OCEANE bondholders at upcoming bondholders meeting Financing would extend cash runway beyond the end of 2027, assuming drawdown of all instalments Proceeds to further strengthen the development of the ACLF pipelineIn return, HCRx will receive a portion of royalties on global1 sales of Iqirvo® (elafibranor) payable to GENFIT under its licensing agreement with Ipsen, up to an agreed upon cap after which all future royalties will revert back to GENFIT GENFIT retains rights to all future regulatory, commercial and sales-based milestone payments from Ipsen...

MaxCyte® Acquires SeQure Dx to Broaden Cell Engineering Offerings with On-target and Off-target Editing Assessments

Written by Customer Service on January 30, 2025. Posted in Mergers And Acquisitions.

ROCKVILLE, Md., Jan. 30, 2025 (GLOBE NEWSWIRE) — MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing solutions to advance the discovery, development and commercialization of next-generation cell therapeutics announced today the acquisition of SeQure Dx, a market leader of on-target and off-target editing assessment services for cell and gene therapies. This strategic acquisition strengthens MaxCyte’s ability to serve ex vivo and in vivo cell and gene therapy (CGT) developers with an innovative suite of tools and services spanning early R&D through clinical development and commercialization. By integrating SeQure Dx into MaxCyte, Maxcyte will expand its service offerings and leverage its commercial and field application scientist teams to work with developers earlier in their research...

SHELL PLC 4th QUARTER 2024 AND FULL YEAR UNAUDITED RESULTS

Written by Customer Service on January 30, 2025. Posted in Earnings Releases And Operating Results.

SHELL PLC4th QUARTER 2024 AND FULL YEAR UNAUDITED RESULTS SUMMARY OF UNAUDITED RESULTSQuarters $ million Full yearQ4 2024 Q3 2024 Q4 2023 %¹ Reference 2024 2023 %928 4,291 474 -78 Income/(loss) attributable to Shell plc shareholders 16,093 19,359 -173,661 6,028 7,306 -39 Adjusted Earnings A 23,716 28,250 -1614,281 16,005 16,335 -11 Adjusted EBITDA A 65,803 68,538 -413,162 14,684 12,575 -10 Cash flow from operating activities 54,684 54,191 +1(4,431) (3,857) (5,657) Cash flow from investing activities (15,154) (17,734) 8,731 10,827 6,918 Free cash flow G 39,530 36,457 6,924 4,950 7,113 Cash capital...

Shell plc Fourth Quarter 2024 Interim Dividend

Written by Customer Service on January 30, 2025. Posted in Dividend Reports And Estimates.

London, January 30, 2025 − The Board of Shell plc (the “Company”) (XLON: SHEL, XNYS: SHEL, XAMS: SHELL) today announced an interim dividend in respect of the fourth quarter of 2024 of US$ 0.358 per ordinary share. Details relating to the fourth quarter 2024 interim dividendPer ordinary share(GB00BP6MXD84) Q4 2024Shell Shares (US$) 0.358Shareholders will be able to elect to receive their dividends in US dollars, euros or pounds sterling. Absent any valid election to the contrary, persons holding their ordinary shares through Euroclear Nederland will receive their dividends in euros. Absent any valid election to the contrary, shareholders (both holding in certificated and uncertificated form (CREST members)) and persons holding their shares through the Shell Corporate Nominee will receive their dividends...

CLIQ Digital Reports Preliminary 2024 Results

Written by Customer Service on January 30, 2025. Posted in Earnings Releases And Operating Results.

CLIQ Digital Reports Preliminary 2024 Results4Q sales declined q/q by 11% to €48m (-26% y/y) Total customer acquisition costs in 4Q improved by 15% q/q (-45% y/y) €21m EBITDA before special items realised in FY (€10m reported EBITDA) €12m net cash position per year-end vs. €16m at end of 2023 Share buyback programme successfully completedDÜSSELDORF, 30 January 2025 – The CLIQ Group announces today its preliminary and unaudited 2024 headline financial results. On 20 February 2025, the audited 2024 Annual Report will be published on the company’s website at https://cliqdigital.com/investors/financialreporting and presented by Management during an earnings call. Performancein millions of € 4Q 2024 3Q 2024 Δ FY2024 FY 2023 ΔSales 48 54 -11% 243 326 -26%Expected average LTV (in €) 70 72 -2% 77 85 -10%Total CAC1 -11 -10 15% -75 -135 -45%EBITDA...

KPN delivered on FY 2024 outlook; on track towards mid-term ambitions

Written by Customer Service on January 30, 2025. Posted in Earnings Releases And Operating Results.

FY24 Group service revenues +3.4% y-on-y (+3.1% organic ), adj. EBITDA AL of € 2,508m (+3.6% y-on-y, or +3.1% excl. Youfone) and FCF of € 900m Continued Group service revenue growth (+2.5% y-on-y, or +2.0% organic) in Q4, with organic growth across all segments Consumer service revenue grew 4.4% y-on-y in Q4, or +1.0% organic Solid commercial momentum in Consumer driving postpaid (+30k) and broadband (+10k) base growth in Q4 Business service revenue grew 2.5% y-on-y in Q4, or +3.1% organic, driven by all divisions Continued to lead the Dutch fiber market; expanded footprint with 574k HP (incl. Glaspoort), record year connecting homes 2025 outlook: Service revenue growth ~3%, adj. EBITDA AL ~€ 2,580m, Capex ~€ 1.25bn and FCF ~€ 910m 7% DPS growth (DPS of € 18.2 cents) and new € 250m share buyback, returning all FCF to shareholders in 2025Program 12:45...

Stolt-Nielsen Limited Reports Unaudited Results For the Fourth Quarter and Full Year 2024

Written by Customer Service on January 30, 2025. Posted in Earnings Releases And Operating Results.

Stolt-Nielsen Limited Reports Unaudited ResultsFor the Fourth Quarter and Full Year 2024 Strong performance in the 2024 financial year LONDON, January 30, 2025 – Stolt-Nielsen Limited (Oslo Børs ticker: SNI) today reported unaudited results for the fourth quarter and full year ended November 30, 2024. The Company reported a fourth-quarter net profit of $91.4 million with revenue of $709.4 million, compared with a net profit of $98.4 million with revenue of $695.2 million in the fourth quarter of 2023. The net profit for 2024 was $394.8 million with revenue of $2,890.6 million, compared with a net profit of $296.7 million, with revenue of $2,820.2 million in 2023. The prior year was negatively impacted by the MSC Flaminia loss provision of $155.0 million. Highlights for the fourth quarter of 2024, compared with the fourth quarter of 2023,...

Day: January 30, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals